CENTENE CORP's gross profit margin for the first quarter of its fiscal year 2015 is essentially unchanged when compared to the same period a year ago. The company has grown sales and net income significantly, outpacing the average growth rates of competitors within its industry. CENTENE CORP has weak liquidity. Currently, the Quick Ratio is 0.92 which shows a lack of ability to cover short-term cash needs. The liquidity decreased from the same period a year ago, despite already having weak liquidity to begin with. This would indicate deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has greatly increased by 30.03% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY15||Q1 FY14|
|Net Sales ($mil)||5131.0||3459.89|
|Net Income ($mil)||63.0||32.98|
|Balance Sheet||Q1 FY15||Q1 FY14|
|Cash & Equiv. ($mil)||1817.0||1317.7|
|Total Assets ($mil)||6696.0||4446.45|
|Total Debt ($mil)||1128.0||817.08|
|Profitability||Q1 FY15||Q1 FY14|
|Gross Profit Margin||10.89||11.15|
|Return on Assets||4.49||3.93|
|Return on Equity||16.23||12.2|
|Debt||Q1 FY15||Q1 FY14|
|Share Data||Q1 FY15||Q1 FY14|
|Shares outstanding (mil)||118.89||115.31|
|Div / share||0.0||0.0|
|Book value / share||15.45||12.25|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1393761.0||819498.0|
BUY. This stock's P/E ratio indicates a premium compared to an average of 27.80 for the Health Care Providers & Services industry and a significant premium compared to the S&P 500 average of 20.31. Conducting a second comparison, its price-to-book ratio of 5.24 indicates a significant premium versus the S&P 500 average of 2.80 and a premium versus the industry average of 3.85. The current price-to-sales ratio is well below the S&P 500 average and is also below the industry average, indicating a discount. After reviewing these and other key valuation criteria, CENTENE CORP proves to trade at a premium to investment alternatives within the industry.
|CNC 32.95||Peers 27.80||CNC 9.50||Peers 16.90|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
CNC is trading at a premium to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CNC is trading at a significant discount to its peers.
|CNC 25.05||Peers 22.47||CNC NM||Peers 1.40|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
CNC is trading at a significant premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CNC's negative PEG ratio makes this valuation measure meaningless.
|CNC 5.24||Peers 3.85||CNC 63.12||Peers 49.29|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CNC is trading at a significant premium to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
CNC is expected to have an earnings growth rate that significantly exceeds its peers.
|CNC 0.53||Peers 0.93||CNC 54.53||Peers 15.23|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CNC is trading at a significant discount to its industry on this measurement.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
CNC has a sales growth rate that significantly exceeds its peers.
Select the service that is right for you!COMPARE ALL SERVICES
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV